Companies in the Materials sector have received a lot of coverage today as analysts weigh in on Barrick Gold (GOLD – Research Report), Taseko Mines (TGB – Research Report) and Ramaco Resources (METC – Research Report).
Barrick Gold (GOLD)
BMO Capital analyst Jackie Przybylowski maintained a Buy rating on Barrick Gold today and set a price target of C$28.00. The company’s shares closed last Tuesday at $16.37, close to its 52-week low of $14.80.
According to TipRanks.com, Przybylowski is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Barrick Gold with a $23.82 average price target, implying a 47.0% upside from current levels. In a report issued on August 1, RBC Capital also maintained a Buy rating on the stock with a $27.00 price target.
Taseko Mines (TGB)
BMO Capital analyst Rene Cartier maintained a Buy rating on Taseko Mines today and set a price target of C$2.50. The company’s shares closed last Tuesday at $1.05, close to its 52-week low of $0.89.
According to TipRanks.com, Cartier is a 4-star analyst with an average return of
Taseko Mines has an analyst consensus of Moderate Buy, with a price target consensus of $1.69.
Ramaco Resources (METC)
BMO Capital analyst David Gagliano maintained a Hold rating on Ramaco Resources today and set a price target of $14.00. The company’s shares closed last Tuesday at $10.60.
According to TipRanks.com, Gagliano is a 4-star analyst with an average return of
Ramaco Resources has an analyst consensus of Moderate Buy, with a price target consensus of $19.50.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on GOLD:
- Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Crispr Therapeutics AG (CRSP) and Annovis Bio (ANVS)
- GE Healthcare in collaboration with Nex Cubed select six digital health start-ups for inaugural Edison Accelerator in Canada
- MacroGenics (MGNX) Gets a Hold from BMO Capital
- BMO Capital Sticks to Their Buy Rating for Precision BioSciences (DTIL)
- BMO Capital Reaffirms Their Buy Rating on Capstone Copper (CSCCF)